Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Infliximab

Brand: Remicade┬«, Inflectra┬«, Remsima┬«
NICE TA: 
Indication: Juvenile Idiopathic Arthritis (JIA) in Adult Patients
Disease category: Musculoskeletal & Joint Diseases
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Treatment with infliximab for adults with JIA is recommended ONLY in the following circumstances in Lancashire:
Young people with JIA currently being treated with one of the agents and transferring over from adolescent to adult services and are benefiting from a clinically effective response

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

Biological Agents For Treating JIA In Adult Patients (Version 2.0) (208.7 KiB)

Biosimilars of Infliximab (Version 1.1) (271.7 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red